| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/24/2002 | WO2002006267A2 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |
| 01/24/2002 | WO2002006259A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv) |
| 01/24/2002 | WO2002006258A1 Azolidines as beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006257A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iii) |
| 01/24/2002 | WO2002006215A1 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivates |
| 01/24/2002 | WO2002005834A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 01/24/2002 | WO2002005819A1 Compounds and methods |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | US20020010340 Process for preparation of 2-aminothiazolecarboxamide derivatives |
| 01/24/2002 | US20020010316 Thiazole derivatives |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | US20020007521 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 01/24/2002 | DE19963234A1 New N,N-disubstituted piperazine and diazacycloheptane derivatives useful in treatment of hyperlipidemia, atherosclerosis, diabetes mellitus, adiposity and pancreatitis |
| 01/24/2002 | DE10034132A1 Heterocyclische Fluoralkenylthioether (lll) Heterocyclic fluoroalkenyl thioethers (III) |
| 01/24/2002 | DE10034130A1 Heterocyclische Fluoralkenylthioether (lV) Heterocyclic fluoroalkenyl thioethers (IV) |
| 01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/23/2002 | EP1174430A1 Process for the preparation of heterocycles by using C1-building blocks |
| 01/23/2002 | EP1174135A2 Pharmaceutical composition for use in treatment of diabetes |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173427A1 Hydroxamic acid derivative |
| 01/23/2002 | EP1173423A1 Benzimidazolones and analogues and their use as progesterone receptor ligands |
| 01/23/2002 | EP1173422A1 Bis-benzazoles and their use as antineoplastic agents |
| 01/23/2002 | EP1173414A1 N-protected amines and their use as prodrugs |
| 01/23/2002 | EP1173176A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 01/23/2002 | EP1173175A1 A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping |
| 01/23/2002 | EP1173169A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 01/23/2002 | EP0846693B1 N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
| 01/23/2002 | CN1332738A 3-(heterocyclyl)-substituted benzoylpyrazols |
| 01/22/2002 | US6340763 Salt formation and crystallization, reaction of halogenated compound and thiourea compound |
| 01/22/2002 | US6340683 Selective NPY (Y5) antagonists (triazines) |
| 01/17/2002 | WO2002004409A2 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders |
| 01/17/2002 | US20020006944 Anticoagulants |
| 01/17/2002 | US20020006941 p53 inhibitors and therapeutic use of the same |
| 01/17/2002 | US20020006924 Mixture of fipronil and antagonist of nicotenic acetylcholine receptors |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/17/2002 | US20020006899 Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | CA2415815A1 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 01/16/2002 | EP0969811B1 Mixtures of alkylphosphoric acid esters and their use as cosmetic and pharmaceutical emulsifiers |
| 01/16/2002 | EP0638075B1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/16/2002 | CN1077769C Synergistic antimicrobial compsns. comprising 2-(thio cyanomethylthio) benzothiazole and organic acid |
| 01/15/2002 | US6339081 Composition and use |
| 01/15/2002 | US6339042 Herbicidal N-cyclohexadienyl heteroaryloxyacetamides |
| 01/10/2002 | WO2002002550A1 Novel pyrazinone derivatives |
| 01/10/2002 | WO2002002542A1 Five-membered-ring compound |
| 01/10/2002 | WO2002002539A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002533A1 Propane-1,3-dione derivatives |
| 01/10/2002 | WO2002002528A1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2001068586A3 α4β1 AND α4β7 INTEGRIN INHIBITORS |
| 01/10/2002 | US20020004516 Use of riluzole in the treating acoustic traumas |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004219 Diagnosis of bacteria infections |
| 01/10/2002 | CA2414461A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2413002A1 Novel pyrazinone derivatives |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices |
| 01/09/2002 | EP1169312A2 Glucokinase activators |
| 01/09/2002 | EP1169311A1 Oxazole and thiazole combinatorial libraries |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
| 01/09/2002 | CN1077427C Skin protecting composition containing acid hydrophilic agent for cosmetic use and application of same |
| 01/08/2002 | US6337340 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 01/08/2002 | CA2080140C Photodynamic plant defoliants and chlorophyll biosynthesis modulators |
| 01/08/2002 | CA2073981C 2-arylthiazole derivatives and pharmaceutical composition thereof |
| 01/03/2002 | WO2002000633A1 Quinolinyl and benzothiazolyl ppar-gamma modulators |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | WO2002000607A1 Amide compounds and use thereof |
| 01/03/2002 | WO2002000602A1 Benzophenones and sulfones as inhibitors of glycine uptake |
| 01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 01/03/2002 | US20020002194 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 01/03/2002 | US20020002193 Thiadiazole antifungal agents |
| 01/03/2002 | US20020002190 Antidiabetic agents increasing the expression of glucokinase (GK) to improve glucose tolerance; increase in glucose exposure coupled through GK in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 01/03/2002 | US20020002186 Pharmaceutical composition |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | DE10030893A1 New N-(2'-hydroxy-5'-aminobenzyl)-2-oxo- and -2-imino-thiazol(id)ine and -imidazol(id)ine compounds are used as developer component in oxidation colorant for keratin fibers, especially hair |
| 01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1167540A2 Dye couple for spectrophotometric determination of analytes |
| 01/02/2002 | EP1165721A2 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring |
| 01/02/2002 | EP1165693A2 Squaraine dyes |
| 01/02/2002 | EP1165531A1 N-adamant-1-yl-n'- 4-chlorobenzothiazol-2-yl] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165529A1 A process for the preparation of thiazolidine derivatives |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | EP1165472A1 Methods for the preparation of biphenyl isoxazole sulfonamides |